UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 573

Sortiert nach

Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy

Neurology, 2007-05, Vol.68 (19), p.1607

2007

Volltextzugriff (PDF)

Plasmapheresis Eliminates the Negative Impact of AAV Antibodies on Microdystrophin Gene Expression Following Vascular Delivery

Molecular therapy, 2014-02, Vol.22 (2), p.338-347

2014

Volltextzugriff (PDF)

Correlating phenotype and genotype in the periodic paralyses

Neurology, 2004-11, Vol.63 (9), p.1647

2004

Volltextzugriff (PDF)

Painful sensory neuropathy: prospective evaluation using skin biopsy

Neurology, 1999-11, Vol.53 (8), p.1641

1999

Volltextzugriff (PDF)

Nonsystemic vasculitic neuropathy: insights from a clinical cohort

Neurology, 2003-09, Vol.61 (5), p.623

2003

Volltextzugriff (PDF)

Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy

Neurology, 2001-10, Vol.57 (8), p.1434

2001

Volltextzugriff (PDF)

Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D

Neurology, 2008-07, Vol.71 (4), p.240

2008

Volltextzugriff (PDF)

Familial cerebellar ataxia with muscle coenzyme Q10 deficiency

Neurology, 2001-04, Vol.56 (7), p.849

2001

Volltextzugriff (PDF)

Autonomic impairment in painful neuropathy

Neurology, 2001-04, Vol.56 (7), p.861

2001

Volltextzugriff (PDF)

Diagnosis of Duchenne dystrophy by enhanced detection of small mutations

Neurology, 2001-08, Vol.57 (4), p.645

2001

Volltextzugriff (PDF)

Intragenic telSMN Mutations: Frequency, Distribution, Evidence of a Founder Effect, and Modification of the Spinal Muscular Atrophy Phenotype by cenSMN Copy Number

American journal of human genetics, 1998-12, Vol.63 (6), p.1712-1723

1998

Volltextzugriff (PDF)

β-Sarcoglycan gene transfer decreases fibrosis and restores force in LGMD2E mice

Gene therapy, 2016-01, Vol.23 (1), p.57-66

2016

Volltextzugriff (PDF)

Painful Sensory Neuropathy

The New England journal of medicine, 2003-03, Vol.348 (13), p.1243-1255

2003

Volltextzugriff (PDF)

AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy

Gene therapy, 2016-01, Vol.23 (1), p.95-102

2016

Volltextzugriff (PDF)

A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy

Neurology, 2001-04, Vol.56 (8), p.1075

2001

Volltextzugriff (PDF)

D.4 Safety and efficacy of delandistrogene moxeparvovec versus placebo in Duchenne muscular dystrophy (EMBARK): Pivotal Phase 3 primary results

Canadian journal of neurological sciences, 2024-06, Vol.51 (s1), p.S9-S10

2024

Volltextzugriff (PDF)

The 2-min walk test is sufficient for evaluating walking abilities in sporadic inclusion body myositis

Neuromuscular disorders : NMD, 2014-03, Vol.24 (3), p.222-226

2014

Volltextzugriff (PDF)

Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy

Neurology, 2001-02, Vol.56 (4), p.445

2001

Volltextzugriff (PDF)

Pilot trial of etanercept in the treatment of inclusion-body myositis

Neurology, 2006-01, Vol.66 (2 Suppl 1), p.S123

2006

Volltextzugriff (PDF)

Definitive molecular diagnosis of facioscapulohumeral dystrophy

Neurology, 1999-06, Vol.52 (9), p.1822

1999

Volltextzugriff (PDF)

Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model

Cell, 2009-06, Vol.137 (6), p.1005-1017

2009

Volltextzugriff (PDF)

Inclusion body myositis and myopathies

Annals of neurology, 1995-11, Vol.38 (5), p.705-713

1995

Volltextzugriff (PDF)

Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials

Journal of the neurological sciences, 2001-08, Vol.189 (1), p.3-5

2001

Volltextzugriff (PDF)

Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number

American journal of human genetics, 1997-06, Vol.60 (6), p.1411-1422

1997

Volltextzugriff (PDF)

Inclusion body myositis: explanation for poor response to immunosuppressive therapy

Neurology, 1995-07, Vol.45 (7), p.1302

1995

Volltextzugriff (PDF)

1 – 25 von 573

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(512)
Mit Volltextzugriff
(431)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(364)
Life Sciences & Biomedicine
(341)
Humans
(330)
Male
(212)
Neurosciences & Neurology
(193)
Clinical Neurology
(166)
Biological And Medical Sciences
(160)
Female
(159)
Medical Sciences
(145)
Neurosciences
(117)
Adult
(105)
Neurology
(103)
Animals
(94)
Child
(89)
Middle Aged
(78)
Adolescent
(70)
Genetics & Heredity
(64)
Child, Preschool
(50)
Muscular Dystrophies - Genetics
(48)
Diseases Of Striated Muscles. Neuromuscular Diseases
(46)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Orthopedic outcomes of long-term daily corticosteroid treatment in Duchenne muscular dystrophy

Plasmapheresis Eliminates the Negative Impact of AAV Antibodies on Microdystrophin Gene Expression Following Vascular Delivery

Correlating phenotype and genotype in the periodic paralyses

Painful sensory neuropathy: prospective evaluation using skin biopsy

Nonsystemic vasculitic neuropathy: insights from a clinical cohort

Randomized, double-blind, placebo-controlled trial of albuterol in facioscapulohumeral dystrophy

Lack of toxicity of alpha-sarcoglycan overexpression supports clinical gene transfer trial in LGMD2D

Familial cerebellar ataxia with muscle coenzyme Q10 deficiency

Autonomic impairment in painful neuropathy

Diagnosis of Duchenne dystrophy by enhanced detection of small mutations

Intragenic telSMN Mutations: Frequency, Distribution, Evidence of a Founder Effect, and Modification of the Spinal Muscular Atrophy Phenotype by cenSMN Copy Number

β-Sarcoglycan gene transfer decreases fibrosis and restores force in LGMD2E mice

Painful Sensory Neuropathy

AAV1.NT-3 gene therapy attenuates spontaneous autoimmune peripheral polyneuropathy

A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy

D.4 Safety and efficacy of delandistrogene moxeparvovec versus placebo in Duchenne muscular dystrophy (EMBARK): Pivotal Phase 3 primary results

The 2-min walk test is sufficient for evaluating walking abilities in sporadic inclusion body myositis

Randomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy

Pilot trial of etanercept in the treatment of inclusion-body myositis

Definitive molecular diagnosis of facioscapulohumeral dystrophy

Therapeutic microRNA Delivery Suppresses Tumorigenesis in a Murine Liver Cancer Model

Inclusion body myositis and myopathies

Positive neuropathic sensory symptoms as endpoints in diabetic neuropathy trials

Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number

Inclusion body myositis: explanation for poor response to immunosuppressive therapy

Suchergebnisse filtern